How much funding has Knopp Biosciences LLC raised?

Knopp Biosciences LLC has raised $32.0M in total funding, most recently a series c round.

When was Knopp Biosciences LLC founded?

Knopp Biosciences LLC was founded in 2016.

Where is Knopp Biosciences LLC headquartered?

Knopp Biosciences LLC is headquartered in Pittsburgh, Pennsylvania, United States.

What industry is Knopp Biosciences LLC in?

Knopp Biosciences LLC operates in Biotech, Healthcare.

How many employees does Knopp Biosciences LLC have?

Knopp Biosciences LLC has 11-50 employees.

Knopp Biosciences LLC

Life Changing Medicine

Pittsburgh, United States · Founded 2016 · $32.0M raised

Biotech

Healthcare

Headquarters: Pittsburgh, Pennsylvania
Employees: 11–50
Founded: 2016
Business Model: B2B

Website: knoppbio.com
Total Funding: $32.0M
Last Round: $14.0M Series CJan 2020

About

Knopp Biosciences LLC is a Pittsburgh-based drug discovery company that spent 18 years developing small-molecule treatments for neurological and immunological diseases, including ALS and epilepsy. The company has since divested its drug platforms — dexpramipexole to Areteia Therapeutics and its Kv7 epilepsy platform to Biohaven Pharmaceuticals — and now operates as a holding entity managing equity and royalties.

Summary

Knopp Biosciences LLC is a Biotech company based in Pittsburgh, United States, founded in 2016. It has raised $32.0M in total, most recently a $14.0M Series C round in Jan 2020.